Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Enlivex Ltd. (ENLV)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 28, 2026 | CORRESP | Neutral/Informational | Moderate | Enlivex Ltd. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form F-3, which was filed on April 21, 2026. They are … | Read Filing EDGAR |
| Apr. 27, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Enlivex Ltd. that it will not review their registration statement filed on April 21, 2026. The letter emphasizes the company's responsibility for the a… | Read Filing EDGAR |
| Dec. 30, 2025 | CORRESP | Neutral/Informational | Moderate | Enlivex Therapeutics Ltd. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form F-3, which was filed on December 23,… | Read Filing EDGAR |
| Dec. 29, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Enlivex Therapeutics Ltd. that it will not review their registration statement filed on December 23, 2025. The letter emphasizes the company's responsi… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.